Review



mgtx  (MedChemExpress)


Bioz Verified Symbol MedChemExpress is a verified supplier
Bioz Manufacturer Symbol MedChemExpress manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 96

    Structured Review

    MedChemExpress mgtx
    Mgtx, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 96/100, based on 504 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/mgtx/product/MedChemExpress
    Average 96 stars, based on 504 article reviews
    mgtx - by Bioz Stars, 2026-03
    96/100 stars

    Images



    Similar Products

    93
    Alomone Labs mgtx
    ( A ) Schematic representation of the tested hypotheses. DP: depolarization; HP: hyperpolarization; Glu: glutamate; DA: dopamine. ( B ) Representative recordings of striatal cholinergic interneurons (SCINs) in response to optogenetic activation of thalamic terminals, with or without margatoxin <t>(MgTx;</t> Kv1.3 channel blocker) or <t>dendrotoxin</t> <t>(DTx;</t> Kv1.1 and Kv1.6 channels blocker) in the bath. ( C ) Pause duration/baseline ISI of SCINs that responded with 1, 2, 3, or 4 spikes to optogenetic activation of thalamic terminals, with or without MgTx 3 nM, 30 nM, or DTx 100 nM, in the bath (two-way RM ANOVA interaction ns, treatment *p=0.0051; control-MgTx 30 nM: *p=0.0005; control-MgTx 3 nM: ns; control-DTX: *p=0.0462; MgTx 30 nM-MgTx 3 nM: *p<0.0001; MgTx 30 nM-DTX: ns; MgTx 3 nM-DTX: *p=0.0027). ( D ) Baseline ISI of SCINs recorded with or without MgTx 3 nM, 30 nM, or DTx (one-way ANOVA, ns). ( E ) Burst duration of SCINs that responded with 2, 3, or 4 spikes to optogenetic activation of thalamic terminals, with or without MgTx 3 nM, 30 nM, or DTx 100 nM, in the bath (two-way RM ANOVA, ns). ( F ) Representative recordings of SCINs in response to optogenetic activation of thalamic terminals, with or without Ba 2+ (10 µM; Kir2.2 channel blocker at this concentration) or XE 991 (10 µM; Kv7 channel blocker) in the bath. ( G ) Pause duration/baseline ISI of SCINs that responded with 1, 2, 3, or 4 spikes to optogenetic activation of thalamic terminals, with or without 10 µM XE 991 or 10 µM Ba 2+ (two-way RM ANOVA, ns). ( H ) Baseline ISI of SCINs recorded with or without Ba 2+ or XE 991 (one-way ANOVA, ns). ( I ) Burst duration of SCINs that responded with 2, 3, or 4 spikes to optogenetic activation of thalamic terminals, for the above conditions (two-way RM ANOVA, ns). Mean ± SEM; n=7–16 cells per group, from >5 mice. Figure 2—source data 1. Contribution of the Kv1 current to the pause response.
    Mgtx, supplied by Alomone Labs, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/mgtx/product/Alomone Labs
    Average 93 stars, based on 1 article reviews
    mgtx - by Bioz Stars, 2026-03
    93/100 stars
      Buy from Supplier

    96
    MedChemExpress mgtx
    ( A ) Schematic representation of the tested hypotheses. DP: depolarization; HP: hyperpolarization; Glu: glutamate; DA: dopamine. ( B ) Representative recordings of striatal cholinergic interneurons (SCINs) in response to optogenetic activation of thalamic terminals, with or without margatoxin <t>(MgTx;</t> Kv1.3 channel blocker) or <t>dendrotoxin</t> <t>(DTx;</t> Kv1.1 and Kv1.6 channels blocker) in the bath. ( C ) Pause duration/baseline ISI of SCINs that responded with 1, 2, 3, or 4 spikes to optogenetic activation of thalamic terminals, with or without MgTx 3 nM, 30 nM, or DTx 100 nM, in the bath (two-way RM ANOVA interaction ns, treatment *p=0.0051; control-MgTx 30 nM: *p=0.0005; control-MgTx 3 nM: ns; control-DTX: *p=0.0462; MgTx 30 nM-MgTx 3 nM: *p<0.0001; MgTx 30 nM-DTX: ns; MgTx 3 nM-DTX: *p=0.0027). ( D ) Baseline ISI of SCINs recorded with or without MgTx 3 nM, 30 nM, or DTx (one-way ANOVA, ns). ( E ) Burst duration of SCINs that responded with 2, 3, or 4 spikes to optogenetic activation of thalamic terminals, with or without MgTx 3 nM, 30 nM, or DTx 100 nM, in the bath (two-way RM ANOVA, ns). ( F ) Representative recordings of SCINs in response to optogenetic activation of thalamic terminals, with or without Ba 2+ (10 µM; Kir2.2 channel blocker at this concentration) or XE 991 (10 µM; Kv7 channel blocker) in the bath. ( G ) Pause duration/baseline ISI of SCINs that responded with 1, 2, 3, or 4 spikes to optogenetic activation of thalamic terminals, with or without 10 µM XE 991 or 10 µM Ba 2+ (two-way RM ANOVA, ns). ( H ) Baseline ISI of SCINs recorded with or without Ba 2+ or XE 991 (one-way ANOVA, ns). ( I ) Burst duration of SCINs that responded with 2, 3, or 4 spikes to optogenetic activation of thalamic terminals, for the above conditions (two-way RM ANOVA, ns). Mean ± SEM; n=7–16 cells per group, from >5 mice. Figure 2—source data 1. Contribution of the Kv1 current to the pause response.
    Mgtx, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/mgtx/product/MedChemExpress
    Average 96 stars, based on 1 article reviews
    mgtx - by Bioz Stars, 2026-03
    96/100 stars
      Buy from Supplier

    93
    Alomone Labs inhibitors pap 1
    ( A ) Schematic representation of the tested hypotheses. DP: depolarization; HP: hyperpolarization; Glu: glutamate; DA: dopamine. ( B ) Representative recordings of striatal cholinergic interneurons (SCINs) in response to optogenetic activation of thalamic terminals, with or without margatoxin <t>(MgTx;</t> Kv1.3 channel blocker) or <t>dendrotoxin</t> <t>(DTx;</t> Kv1.1 and Kv1.6 channels blocker) in the bath. ( C ) Pause duration/baseline ISI of SCINs that responded with 1, 2, 3, or 4 spikes to optogenetic activation of thalamic terminals, with or without MgTx 3 nM, 30 nM, or DTx 100 nM, in the bath (two-way RM ANOVA interaction ns, treatment *p=0.0051; control-MgTx 30 nM: *p=0.0005; control-MgTx 3 nM: ns; control-DTX: *p=0.0462; MgTx 30 nM-MgTx 3 nM: *p<0.0001; MgTx 30 nM-DTX: ns; MgTx 3 nM-DTX: *p=0.0027). ( D ) Baseline ISI of SCINs recorded with or without MgTx 3 nM, 30 nM, or DTx (one-way ANOVA, ns). ( E ) Burst duration of SCINs that responded with 2, 3, or 4 spikes to optogenetic activation of thalamic terminals, with or without MgTx 3 nM, 30 nM, or DTx 100 nM, in the bath (two-way RM ANOVA, ns). ( F ) Representative recordings of SCINs in response to optogenetic activation of thalamic terminals, with or without Ba 2+ (10 µM; Kir2.2 channel blocker at this concentration) or XE 991 (10 µM; Kv7 channel blocker) in the bath. ( G ) Pause duration/baseline ISI of SCINs that responded with 1, 2, 3, or 4 spikes to optogenetic activation of thalamic terminals, with or without 10 µM XE 991 or 10 µM Ba 2+ (two-way RM ANOVA, ns). ( H ) Baseline ISI of SCINs recorded with or without Ba 2+ or XE 991 (one-way ANOVA, ns). ( I ) Burst duration of SCINs that responded with 2, 3, or 4 spikes to optogenetic activation of thalamic terminals, for the above conditions (two-way RM ANOVA, ns). Mean ± SEM; n=7–16 cells per group, from >5 mice. Figure 2—source data 1. Contribution of the Kv1 current to the pause response.
    Inhibitors Pap 1, supplied by Alomone Labs, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/inhibitors pap 1/product/Alomone Labs
    Average 93 stars, based on 1 article reviews
    inhibitors pap 1 - by Bioz Stars, 2026-03
    93/100 stars
      Buy from Supplier

    93
    Alomone Labs margatoxin mrgx
    ( A ) Schematic representation of the tested hypotheses. DP: depolarization; HP: hyperpolarization; Glu: glutamate; DA: dopamine. ( B ) Representative recordings of striatal cholinergic interneurons (SCINs) in response to optogenetic activation of thalamic terminals, with or without margatoxin <t>(MgTx;</t> Kv1.3 channel blocker) or <t>dendrotoxin</t> <t>(DTx;</t> Kv1.1 and Kv1.6 channels blocker) in the bath. ( C ) Pause duration/baseline ISI of SCINs that responded with 1, 2, 3, or 4 spikes to optogenetic activation of thalamic terminals, with or without MgTx 3 nM, 30 nM, or DTx 100 nM, in the bath (two-way RM ANOVA interaction ns, treatment *p=0.0051; control-MgTx 30 nM: *p=0.0005; control-MgTx 3 nM: ns; control-DTX: *p=0.0462; MgTx 30 nM-MgTx 3 nM: *p<0.0001; MgTx 30 nM-DTX: ns; MgTx 3 nM-DTX: *p=0.0027). ( D ) Baseline ISI of SCINs recorded with or without MgTx 3 nM, 30 nM, or DTx (one-way ANOVA, ns). ( E ) Burst duration of SCINs that responded with 2, 3, or 4 spikes to optogenetic activation of thalamic terminals, with or without MgTx 3 nM, 30 nM, or DTx 100 nM, in the bath (two-way RM ANOVA, ns). ( F ) Representative recordings of SCINs in response to optogenetic activation of thalamic terminals, with or without Ba 2+ (10 µM; Kir2.2 channel blocker at this concentration) or XE 991 (10 µM; Kv7 channel blocker) in the bath. ( G ) Pause duration/baseline ISI of SCINs that responded with 1, 2, 3, or 4 spikes to optogenetic activation of thalamic terminals, with or without 10 µM XE 991 or 10 µM Ba 2+ (two-way RM ANOVA, ns). ( H ) Baseline ISI of SCINs recorded with or without Ba 2+ or XE 991 (one-way ANOVA, ns). ( I ) Burst duration of SCINs that responded with 2, 3, or 4 spikes to optogenetic activation of thalamic terminals, for the above conditions (two-way RM ANOVA, ns). Mean ± SEM; n=7–16 cells per group, from >5 mice. Figure 2—source data 1. Contribution of the Kv1 current to the pause response.
    Margatoxin Mrgx, supplied by Alomone Labs, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/margatoxin mrgx/product/Alomone Labs
    Average 93 stars, based on 1 article reviews
    margatoxin mrgx - by Bioz Stars, 2026-03
    93/100 stars
      Buy from Supplier

    93
    MedChemExpress margatoxin mgtx
    ( A ) Schematic representation of the tested hypotheses. DP: depolarization; HP: hyperpolarization; Glu: glutamate; DA: dopamine. ( B ) Representative recordings of striatal cholinergic interneurons (SCINs) in response to optogenetic activation of thalamic terminals, with or without margatoxin <t>(MgTx;</t> Kv1.3 channel blocker) or <t>dendrotoxin</t> <t>(DTx;</t> Kv1.1 and Kv1.6 channels blocker) in the bath. ( C ) Pause duration/baseline ISI of SCINs that responded with 1, 2, 3, or 4 spikes to optogenetic activation of thalamic terminals, with or without MgTx 3 nM, 30 nM, or DTx 100 nM, in the bath (two-way RM ANOVA interaction ns, treatment *p=0.0051; control-MgTx 30 nM: *p=0.0005; control-MgTx 3 nM: ns; control-DTX: *p=0.0462; MgTx 30 nM-MgTx 3 nM: *p<0.0001; MgTx 30 nM-DTX: ns; MgTx 3 nM-DTX: *p=0.0027). ( D ) Baseline ISI of SCINs recorded with or without MgTx 3 nM, 30 nM, or DTx (one-way ANOVA, ns). ( E ) Burst duration of SCINs that responded with 2, 3, or 4 spikes to optogenetic activation of thalamic terminals, with or without MgTx 3 nM, 30 nM, or DTx 100 nM, in the bath (two-way RM ANOVA, ns). ( F ) Representative recordings of SCINs in response to optogenetic activation of thalamic terminals, with or without Ba 2+ (10 µM; Kir2.2 channel blocker at this concentration) or XE 991 (10 µM; Kv7 channel blocker) in the bath. ( G ) Pause duration/baseline ISI of SCINs that responded with 1, 2, 3, or 4 spikes to optogenetic activation of thalamic terminals, with or without 10 µM XE 991 or 10 µM Ba 2+ (two-way RM ANOVA, ns). ( H ) Baseline ISI of SCINs recorded with or without Ba 2+ or XE 991 (one-way ANOVA, ns). ( I ) Burst duration of SCINs that responded with 2, 3, or 4 spikes to optogenetic activation of thalamic terminals, for the above conditions (two-way RM ANOVA, ns). Mean ± SEM; n=7–16 cells per group, from >5 mice. Figure 2—source data 1. Contribution of the Kv1 current to the pause response.
    Margatoxin Mgtx, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/margatoxin mgtx/product/MedChemExpress
    Average 93 stars, based on 1 article reviews
    margatoxin mgtx - by Bioz Stars, 2026-03
    93/100 stars
      Buy from Supplier

    Image Search Results


    ( A ) Schematic representation of the tested hypotheses. DP: depolarization; HP: hyperpolarization; Glu: glutamate; DA: dopamine. ( B ) Representative recordings of striatal cholinergic interneurons (SCINs) in response to optogenetic activation of thalamic terminals, with or without margatoxin (MgTx; Kv1.3 channel blocker) or dendrotoxin (DTx; Kv1.1 and Kv1.6 channels blocker) in the bath. ( C ) Pause duration/baseline ISI of SCINs that responded with 1, 2, 3, or 4 spikes to optogenetic activation of thalamic terminals, with or without MgTx 3 nM, 30 nM, or DTx 100 nM, in the bath (two-way RM ANOVA interaction ns, treatment *p=0.0051; control-MgTx 30 nM: *p=0.0005; control-MgTx 3 nM: ns; control-DTX: *p=0.0462; MgTx 30 nM-MgTx 3 nM: *p<0.0001; MgTx 30 nM-DTX: ns; MgTx 3 nM-DTX: *p=0.0027). ( D ) Baseline ISI of SCINs recorded with or without MgTx 3 nM, 30 nM, or DTx (one-way ANOVA, ns). ( E ) Burst duration of SCINs that responded with 2, 3, or 4 spikes to optogenetic activation of thalamic terminals, with or without MgTx 3 nM, 30 nM, or DTx 100 nM, in the bath (two-way RM ANOVA, ns). ( F ) Representative recordings of SCINs in response to optogenetic activation of thalamic terminals, with or without Ba 2+ (10 µM; Kir2.2 channel blocker at this concentration) or XE 991 (10 µM; Kv7 channel blocker) in the bath. ( G ) Pause duration/baseline ISI of SCINs that responded with 1, 2, 3, or 4 spikes to optogenetic activation of thalamic terminals, with or without 10 µM XE 991 or 10 µM Ba 2+ (two-way RM ANOVA, ns). ( H ) Baseline ISI of SCINs recorded with or without Ba 2+ or XE 991 (one-way ANOVA, ns). ( I ) Burst duration of SCINs that responded with 2, 3, or 4 spikes to optogenetic activation of thalamic terminals, for the above conditions (two-way RM ANOVA, ns). Mean ± SEM; n=7–16 cells per group, from >5 mice. Figure 2—source data 1. Contribution of the Kv1 current to the pause response.

    Journal: eLife

    Article Title: Striatal cholinergic interneuron pause response requires Kv1 channels, is absent in dyskinetic mice, and is restored by dopamine D5 receptor inverse agonism

    doi: 10.7554/eLife.102184

    Figure Lengend Snippet: ( A ) Schematic representation of the tested hypotheses. DP: depolarization; HP: hyperpolarization; Glu: glutamate; DA: dopamine. ( B ) Representative recordings of striatal cholinergic interneurons (SCINs) in response to optogenetic activation of thalamic terminals, with or without margatoxin (MgTx; Kv1.3 channel blocker) or dendrotoxin (DTx; Kv1.1 and Kv1.6 channels blocker) in the bath. ( C ) Pause duration/baseline ISI of SCINs that responded with 1, 2, 3, or 4 spikes to optogenetic activation of thalamic terminals, with or without MgTx 3 nM, 30 nM, or DTx 100 nM, in the bath (two-way RM ANOVA interaction ns, treatment *p=0.0051; control-MgTx 30 nM: *p=0.0005; control-MgTx 3 nM: ns; control-DTX: *p=0.0462; MgTx 30 nM-MgTx 3 nM: *p<0.0001; MgTx 30 nM-DTX: ns; MgTx 3 nM-DTX: *p=0.0027). ( D ) Baseline ISI of SCINs recorded with or without MgTx 3 nM, 30 nM, or DTx (one-way ANOVA, ns). ( E ) Burst duration of SCINs that responded with 2, 3, or 4 spikes to optogenetic activation of thalamic terminals, with or without MgTx 3 nM, 30 nM, or DTx 100 nM, in the bath (two-way RM ANOVA, ns). ( F ) Representative recordings of SCINs in response to optogenetic activation of thalamic terminals, with or without Ba 2+ (10 µM; Kir2.2 channel blocker at this concentration) or XE 991 (10 µM; Kv7 channel blocker) in the bath. ( G ) Pause duration/baseline ISI of SCINs that responded with 1, 2, 3, or 4 spikes to optogenetic activation of thalamic terminals, with or without 10 µM XE 991 or 10 µM Ba 2+ (two-way RM ANOVA, ns). ( H ) Baseline ISI of SCINs recorded with or without Ba 2+ or XE 991 (one-way ANOVA, ns). ( I ) Burst duration of SCINs that responded with 2, 3, or 4 spikes to optogenetic activation of thalamic terminals, for the above conditions (two-way RM ANOVA, ns). Mean ± SEM; n=7–16 cells per group, from >5 mice. Figure 2—source data 1. Contribution of the Kv1 current to the pause response.

    Article Snippet: The following stock solvents and final concentrations were used: distilled H 2 O for BaCl (10 μM), ZD7288 (30 μM), mecamylamine (10 μM, RBI), methiothepin (10 μM), quinpirole (1 μM, 10 μM), and sumanirole (10 μM); DMSO for CNQX (40 μM, Tocris), PIC (100 μM), SKF81297 (2 μM), SCH23390 (10 μM), sulpiride (10 μM, Santa Cruz Biotechnology), XE991 (10 μM), and clozapine (10 μM, Rospaw Laboratory); and the manufacturer’s recommended storage buffer (0.1% BSA, 100 mM NaCl, 10 mM Tris pH 7.5, 1 mM EDTA) for MgTx (3 nM and 30 nM, Alomone Labs) and g-DTx (100 nM, Alomone Labs).

    Techniques: Activation Assay, Control, Concentration Assay